NCT00004260
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,963 public trials
2,020 recruiting studies
Immunoproliferative Disorders trial results
NCT00006362
- Conditions
- Amyloidosis, Blood Protein Disorders, Burkitt Lymphoma, +50 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
NCT00002693
- Conditions
- Agranulocytosis, Blast Crisis, Bone Marrow Diseases, +27 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00263484
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Tata Memorial Hospital Mumbai, India
- Christian Medical College Vellore, Tamil Nadu, India
- Singapore General Hospital Singapore
- National Cancer Centre, Singapore Singapore
NCT00089037
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00782145
- Conditions
- Adnexal Diseases, Blast Crisis, Bone Marrow Diseases, +70 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT00466583
- Conditions
- Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States
Completed
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
NCT00286832
- Conditions
- Diffuse Large-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Department of Hematology, Odense University Hospital Odense, Denmark
NCT00709813
- Conditions
- Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
Not specified
NCT00104104
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hematology Oncology Specialists Huntsville, Alabama, United States
- Palo Verde Hematology Oncology Glendale, Arizona, United States
- US Oncology Tucson, Arizona, United States
- Myeloma Institute For Research Therapy Little Rock, Arkansas, United States